Free Trial

Nova (NVMI) Competitors

Nova logo
$244.91 +2.58 (+1.06%)
As of 04:00 PM Eastern

NVMI vs. VLTO, TER, AVTR, RVTY, BIO.B, VNT, ST, CAMT, MIR, and TXG

Should you be buying Nova stock or one of its competitors? The main competitors of Nova include Veralto (VLTO), Teradyne (TER), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Vontier (VNT), Sensata Technologies (ST), Camtek (CAMT), Mirion Technologies (MIR), and 10x Genomics (TXG). These companies are all part of the "measuring and control equipment" industry.

Nova vs.

Nova (NASDAQ:NVMI) and Veralto (NYSE:VLTO) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Nova currently has a consensus price target of $238.33, suggesting a potential downside of 1.63%. Veralto has a consensus price target of $113.27, suggesting a potential upside of 9.63%. Given Veralto's higher probable upside, analysts clearly believe Veralto is more favorable than Nova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nova
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Veralto
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

Nova has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Veralto has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.

83.0% of Nova shares are owned by institutional investors. Comparatively, 91.3% of Veralto shares are owned by institutional investors. 1.0% of Nova shares are owned by company insiders. Comparatively, 0.3% of Veralto shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Nova had 3 more articles in the media than Veralto. MarketBeat recorded 15 mentions for Nova and 12 mentions for Veralto. Nova's average media sentiment score of 0.74 beat Veralto's score of 0.02 indicating that Nova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nova
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Veralto
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

Veralto has higher revenue and earnings than Nova. Veralto is trading at a lower price-to-earnings ratio than Nova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nova$517.92M13.59$136.31M$5.3645.20
Veralto$5.02B5.09$839M$3.2431.89

Nova has a net margin of 28.00% compared to Veralto's net margin of 15.69%. Veralto's return on equity of 52.85% beat Nova's return on equity.

Company Net Margins Return on Equity Return on Assets
Nova28.00% 21.35% 14.34%
Veralto 15.69%52.85%14.60%

Nova received 432 more outperform votes than Veralto when rated by MarketBeat users. Likewise, 74.38% of users gave Nova an outperform vote while only 52.94% of users gave Veralto an outperform vote.

CompanyUnderperformOutperform
NovaOutperform Votes
450
74.38%
Underperform Votes
155
25.62%
VeraltoOutperform Votes
18
52.94%
Underperform Votes
16
47.06%

Summary

Nova beats Veralto on 12 of the 18 factors compared between the two stocks.

Get Nova News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVMI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVMI vs. The Competition

MetricNovaOptical instruments & lenses IndustryComputer SectorNASDAQ Exchange
Market Cap$7.03B$18.31B$27.00B$9.15B
Dividend YieldN/A1.25%2.79%4.04%
P/E Ratio45.1522.37236.0217.31
Price / Sales13.597.763,219.53136.64
Price / Cash40.7321.3134.2435.97
Price / Book9.368.268.354.79
Net Income$136.31M$354.80M$669.74M$224.91M
7 Day Performance11.28%0.55%1.61%1.68%
1 Month Performance22.58%-0.15%3.51%2.17%
1 Year Performance83.04%30.72%26.90%20.77%

Nova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVMI
Nova
1.7939 of 5 stars
$244.91
+1.1%
$238.33
-2.7%
+81.4%$7.11B$517.92M45.693,606Analyst Revision
News Coverage
VLTO
Veralto
2.5482 of 5 stars
$100.47
+0.4%
$113.27
+12.7%
+39.6%$24.85B$5.14B31.0116,000Short Interest ↑
TER
Teradyne
4.667 of 5 stars
$132.54
-1.2%
$150.33
+13.4%
+32.2%$21.59B$2.74B42.086,500Short Interest ↑
AVTR
Avantor
4.0199 of 5 stars
$21.89
+1.1%
$27.69
+26.5%
+3.5%$14.90B$6.82B47.5914,500Analyst Forecast
Options Volume
News Coverage
RVTY
Revvity
3.594 of 5 stars
$121.79
+6.9%
$131.93
+8.3%
+10.4%$14.82B$2.72B58.8411,500
BIO.B
Bio-Rad Laboratories
N/A$341.00
flat
N/A+7.5%$9.55B$2.58B-12.488,200
VNT
Vontier
3.8925 of 5 stars
$35.83
-0.4%
$44.63
+24.5%
+9.0%$5.38B$2.99B13.738,000Short Interest ↓
ST
Sensata Technologies
4.734 of 5 stars
$27.45
+0.7%
$41.00
+49.4%
-17.4%$4.11B$4.02B-50.8320,800Analyst Forecast
News Coverage
CAMT
Camtek
3.7929 of 5 stars
$86.40
-3.5%
$110.78
+28.2%
+33.6%$3.92B$400.63M39.82400Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
Gap Up
MIR
Mirion Technologies
2.7832 of 5 stars
$15.75
-0.9%
$19.25
+22.2%
+69.2%$3.66B$836.90M-46.323,000Gap Down
TXG
10x Genomics
4.5739 of 5 stars
$15.52
-0.4%
$23.86
+53.7%
-66.1%$1.88B$629.74M-10.141,240News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:NVMI) was last updated on 1/17/2025 by MarketBeat.com Staff
From Our Partners